Micro-X Ltd
ASX:MX1
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Micro-X Ltd
PP&E Net
Micro-X Ltd
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Micro-X Ltd
ASX:MX1
|
PP&E Net
AU$7.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
PP&E Net
AU$1.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
46%
|
CAGR 10-Years
20%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
PP&E Net
AU$9.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
30%
|
CAGR 10-Years
26%
|
Cochlear Ltd
ASX:COH
|
PP&E Net
AU$455.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
PP&E Net
AU$481.9k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
32%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
PP&E Net
AU$803.4k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Micro-X Ltd's PP&E Net?
PP&E Net
7.2m
AUD
Based on the financial report for Dec 31, 2023, Micro-X Ltd's PP&E Net amounts to 7.2m AUD.
What is Micro-X Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
68%
Over the last year, the PP&E Net growth was -11%. The average annual PP&E Net growth rates for Micro-X Ltd have been -2% over the past three years , 68% over the past five years .